CompaniesByCap
CSTL
Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare

Castle Biosciences, Inc. Income Statement 2018–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenues
Revenue344.2M332.1M219.8M137.0M94.1M62.6M51.9M22.8M
Gross Profit273.2M271.9M174.8M105.0M78.3M53.0M44.6M17.5M
Profitability
Operating Income-42.8M8.7M-68.0M-72.9M-40.1M-6.5M7.3M-3.8M
EBITDA-2.0M24.7M-55.6M-62.3M-36.7M-6.1M
Net Income-24.2M18.2M-57.5M-67.1M-31.3M-10.3M5.3M-6.4M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)29M29M27M26M25M19M9M2M

Castle Biosciences, Inc. Income Statement — FAQ

Castle Biosciences, Inc. (CSTL) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CSTL's income statement history?

The chart and table above show Castle Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.